Abstract
Recent progress in elucidating the mechanisms underlying human disease has dramatically increased the number of protein targets available for potential drug treatment. Concurrently, new approaches have increased the number of compounds that can be tested for activity against these targets. Together, these trends have stimulated the adoption of high-throughput screening as a primary tool for early-stage drug discovery.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 14-16 |
| Number of pages | 3 |
| Journal | Nature |
| Volume | 384 |
| Issue number | 6604 SUPPL. |
| DOIs | |
| State | Published - Nov 7 1996 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- General
Fingerprint
Dive into the research topics of 'High-throughput screening for drug discovery'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver